COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Reissuance of Clinical Proteomic Tumor Analysis Consortium

Type: 
Notice
Expiration Date: 
Saturday, July 31, 2021

The National Cancer Institute is soliciting applications for the reissuance of its Clinical Proteomic Tumor Analysis Consortium (CPTAC). This re-issuance seeks to continue building on the current achievements in clinical cancer proteogenomics discoveries and infrastructure to accelerate molecularly oriented cancer research toward basic discovery and clinical impact. FOAs are open to all qualified applicants regardless of whether or not they participated in the previous issuance of the CPTAC program.

Title: Proteome Characterization Centers (PCCs) for Clinical Proteomic Tumor Analysis Consortium (Clinical Trial Not Allowed)
Announcement Number: RFA-CA-21-023
Letter of Intent Due Date: 30 days prior to application due date
Application Due Date: June 30, 2021
Activity Code: U24, Resource-Related Research Projects - Cooperative Agreements

Title: Proteogenomic Data Analysis Centers (PGDACs) for Clinical Proteomic Tumor Analysis Consortium (Clinical Trial Not Allowed)
Announcement Number: RFA-CA-21-024
Letter of Intent Due Date: 30 days prior to application due date
Application Due Date: June 30, 2021
Activity Code: U24, Resource-Related Research Projects - Cooperative Agreements

Title: Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (Clinical Trial Not Allowed)
Announcement Number: RFA-CA-21-025
Letter of Intent Due Date: 30 days prior to application due date
Application Due Date: July 30, 2021
Activity Code: U01, Research Project - Cooperative Agreements


Frequently Asked Questions (coming soon)

RFA-CA-21-023

RFA-CA-21-024

RFA-CA-21-025